Timothy Chiang
Stock Analyst
(n/a)
# 4,633
Out of 4,641 analysts
6
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Timothy Chiang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Initiates: Overweight | n/a | $59.04 | - | 1 | Mar 15, 2024 | |
| AKYA Akoya Biosciences | Initiates: Overweight | $19 | $2.80 | +578.57% | 1 | Nov 3, 2022 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $55 | $46.59 | +18.05% | 2 | Feb 11, 2022 | |
| AMPH Amphastar Pharmaceuticals | Upgrades: Outperform | n/a | $49.83 | - | 1 | Oct 5, 2020 | |
| IDYA IDEAYA Biosciences | Initiates: Outperform | $28 | $29.50 | -5.08% | 1 | Sep 1, 2020 |
ANI Pharmaceuticals
Mar 15, 2024
Initiates: Overweight
Price Target: n/a
Current: $59.04
Upside: -
Akoya Biosciences
Nov 3, 2022
Initiates: Overweight
Price Target: $19
Current: $2.80
Upside: +578.57%
Protagonist Therapeutics
Feb 11, 2022
Initiates: Buy
Price Target: $55
Current: $46.59
Upside: +18.05%
Amphastar Pharmaceuticals
Oct 5, 2020
Upgrades: Outperform
Price Target: n/a
Current: $49.83
Upside: -
IDEAYA Biosciences
Sep 1, 2020
Initiates: Outperform
Price Target: $28
Current: $29.50
Upside: -5.08%